Guangdong Lifestrong Pharmacy Co., Ltd.

SZSE:301111 Stock Report

Market Cap: CN¥2.7b

Guangdong Lifestrong Pharmacy Balance Sheet Health

Financial Health criteria checks 6/6

Guangdong Lifestrong Pharmacy has a total shareholder equity of CN¥779.2M and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥857.0M and CN¥77.8M respectively. Guangdong Lifestrong Pharmacy's EBIT is CN¥2.5M making its interest coverage ratio -0.2. It has cash and short-term investments of CN¥335.9M.

Key information

0%

Debt to equity ratio

CN¥0

Debt

Interest coverage ratio-0.2x
CashCN¥335.93m
EquityCN¥779.21m
Total liabilitiesCN¥77.78m
Total assetsCN¥856.99m

Recent financial health updates

No updates

Recent updates

What Guangdong Lifestrong Pharmacy Co., Ltd.'s (SZSE:301111) 25% Share Price Gain Is Not Telling You

Dec 02
What Guangdong Lifestrong Pharmacy Co., Ltd.'s (SZSE:301111) 25% Share Price Gain Is Not Telling You

Guangdong Lifestrong Pharmacy's (SZSE:301111) Anemic Earnings Might Be Worse Than You Think

Nov 04
Guangdong Lifestrong Pharmacy's (SZSE:301111) Anemic Earnings Might Be Worse Than You Think

Investor Optimism Abounds Guangdong Lifestrong Pharmacy Co., Ltd. (SZSE:301111) But Growth Is Lacking

Oct 02
Investor Optimism Abounds Guangdong Lifestrong Pharmacy Co., Ltd. (SZSE:301111) But Growth Is Lacking

Guangdong Lifestrong Pharmacy's (SZSE:301111) Problems Go Beyond Weak Profit

May 03
Guangdong Lifestrong Pharmacy's (SZSE:301111) Problems Go Beyond Weak Profit

What Guangdong Lifestrong Pharmacy Co., Ltd.'s (SZSE:301111) 28% Share Price Gain Is Not Telling You

Mar 06
What Guangdong Lifestrong Pharmacy Co., Ltd.'s (SZSE:301111) 28% Share Price Gain Is Not Telling You

Financial Position Analysis

Short Term Liabilities: 301111's short term assets (CN¥531.0M) exceed its short term liabilities (CN¥75.1M).

Long Term Liabilities: 301111's short term assets (CN¥531.0M) exceed its long term liabilities (CN¥2.7M).


Debt to Equity History and Analysis

Debt Level: 301111 is debt free.

Reducing Debt: 301111 had no debt 5 years ago.

Debt Coverage: 301111 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 301111 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/30 19:57
End of Day Share Price 2024/12/30 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Guangdong Lifestrong Pharmacy Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution